Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 20, 2006 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 236,536 |
Dec 18, 2006 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
Dec 18, 2006 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,079 | -- | 70,079 |
Dec 18, 2006 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
Dec 18, 2006 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 35,079 | -- | 35,079 |
Dec 18, 2006 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 |
Dec 18, 2006 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,966 | -- | 4,966 |
Dec 18, 2006 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,034 | -- | 25,034 |
Dec 18, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
Dec 18, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,079 | -- | 70,079 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.